| Peritoneal Malignant Mesothelioma studied in …STUDIED_INderived11 of 11show fewer |
|---|
| → studied in | NCT06057935Phase 2 · recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001880Phase 2 · recruiting Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535312Phase 1/Phase 2 · active not recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756035Phase 1 · recruiting CT-95 in Advanced Cancers Associated With Mesothelin Expression · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05449366Phase 1/Phase 2 · completed Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543069Phase 2 · recruiting Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM · condition mapped CURATED_BROADER · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05193006unknown Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02151448Phase 1/Phase 2 · completed αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies · condition mapped ALIAS · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01592383Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 11 trials mapped (6 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |